Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection

Cefiderocol is a novel siderophore cephalosporin with antibacterial activity against Gram-negative bacteria, including carbapenem-resistant strains. The standard dosing regimen of cefiderocol is 2 g administered every 8 hours over 3 hours infusion in patients with creatinine clearance (CrCL) of 60 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Nao, Katsube, Takayuki, Echols, Roger, Wajima, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092503/
https://www.ncbi.nlm.nih.gov/pubmed/33257454
http://dx.doi.org/10.1128/AAC.01437-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092503/
https://www.ncbi.nlm.nih.gov/pubmed/33257454
http://dx.doi.org/10.1128/AAC.01437-20

Ejemplares similares